Trial Profile
Phase 1 trial of remimazolam for procedural sedation (third trial to complement the phase 3 trials)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Adverse reactions
- Sponsors PAION
- 16 Mar 2017 Status changed from recruiting to completed, as reported in a PAION media release.
- 08 Apr 2015 New trial record